Sofinnova Investments’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,616
| Closed | -$568K | – | 77 |
|
|
2024
Q4 | $568K | Buy |
+32,616
| New | +$568K | 0.04% | 57 |
|
|
2023
Q2 | – | Sell |
-1,263,721
| Closed | -$28.4M | – | 59 |
|
|
2023
Q1 | $28.4M | Buy |
1,263,721
+685,453
| +119% | +$15.4M | 1.82% | 13 |
|
|
2022
Q4 | $12.2M | Buy |
578,268
+183,590
| +47% | +$3.86M | 0.72% | 28 |
|
|
2022
Q3 | $9.73M | Buy |
394,678
+182,085
| +86% | +$4.49M | 0.57% | 30 |
|
|
2022
Q2 | $5.15M | Sell |
212,593
-445,656
| -68% | -$10.8M | 0.43% | 36 |
|
|
2022
Q1 | $17M | Sell |
658,249
-382,609
| -37% | -$9.86M | 1.29% | 18 |
|
|
2021
Q4 | $32.3M | Buy |
1,040,858
+603,578
| +138% | +$18.7M | 1.89% | 10 |
|
|
2021
Q3 | $10.6M | Buy |
+437,280
| New | +$10.6M | 0.63% | 31 |
|